Media Summary: Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025? What Matters Most? The questions every hepatologist should ask their patients In hepatology, effective care goes beyond ... Treating PBC: Alkaline Phosphatase response or improvement in liver stiffness? This episode shifts the focus from symptoms and ...
Easl Studio Promo - Detailed Analysis & Overview
Hepatitis C, Re-infection or Failure of Treatment in People Engaging in High Risk Practices – Do These Labels Matter in 2025? What Matters Most? The questions every hepatologist should ask their patients In hepatology, effective care goes beyond ... Treating PBC: Alkaline Phosphatase response or improvement in liver stiffness? This episode shifts the focus from symptoms and ... Sarcopenia: Converting research findings into clinical practice – Are we doing enough? Sarcopenia, defined by a reduction in ... After years of limited progress, recent trials hint at a changing landscape for primary sclerosing cholangitis (PSC). In this episode ... This episode questions whether assigning the label “ACLF” to a deteriorating patient truly alters clinical decisions, or if focusing on ...
This episode celebrates 40 years of the Journal of Hepatology, The impact of policy measure in preventing liver diseases: The Hepahealth II study This episode will treat of the Hepahealth II ... This episode will discuss patient priorities in primary biliary cholangitis. The management of abnormal liver blood tests has ... In this next LIVE episode we will be shining the spotlight on really exciting news straight from the AASLD Liver Meeting. Join us for ... In this episode, the panellists will evaluate past efforts, current trials, and the evolving landscape of HBV cure research. They will ... Join us for a critical discussion on the significance of Drug and Herbal & Dietary Supplement-Induced Liver Injury (DHILI).
